Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
02/01/2012 | CN102336815A Treatment of viral infections |
02/01/2012 | CN102336812A Polypeptide possessing angiogenesis inhibitory activity |
02/01/2012 | CN102336811A Novel small peptide capable of inhibiting new vessels and application thereof |
02/01/2012 | CN102335414A Rice prolamin bile acid adsorbent and preparation method thereof |
02/01/2012 | CN101948528B 一种来自斑蝥的纤溶活性蛋白及其制备方法和应用 Fibrinolytic activity of the protein and its preparation method and application of cantharidin from |
02/01/2012 | CN101845088B 与铵盐吸收相关的蛋白及其编码基因与应用 Protein and its encoding gene with an ammonium salt absorption and application-related |
02/01/2012 | CN101838325B 猪用抗原呈递蛋白及其编码基因和应用 Pig protein and the gene encoding the antigen-presenting and applications |
02/01/2012 | CN101817875B 一种水稻不定根突出控制基因OsDARE1及其用途 Outstanding control of a Rice Gene OsDARE1 adventitious roots and their use |
02/01/2012 | CN101805395B 具有抑制病毒混合感染活性的多肽 Inhibit the activity of mixed infection polypeptide |
02/01/2012 | CN101747420B 一种水稻显性矮秆相关蛋白及其编码基因与应用 Of a Rice Dwarf dominant protein and its encoding gene associated with the application |
02/01/2012 | CN101709083B 一种来自蝎尾的纤溶活性蛋白及其制备方法和应用 A fibrinolytic activity protein and its preparation method and application from Heliconia's |
02/01/2012 | CN101658129B 雌性不育基因fst用于杂交水稻育种的方法 Female sterility gene fst method for hybrid rice breeding |
02/01/2012 | CN101628934B 与水苏糖合成相关的蛋白及其编码基因与应用 Protein coding gene and application and stachyose synthesis related |
02/01/2012 | CN101429239B 一种抗动脉粥样硬化的表位组合物、其制备方法及用途 An anti-atherosclerotic epitope composition, preparation and uses |
02/01/2012 | CN101337987B 一种用于抗白内障的靶蛋白 An anti-cataract target protein |
02/01/2012 | CN101316860B 高官能、高支化或超支化聚赖氨酸的生产和用途 High functionality, highly branched or hyperbranched poly-lysine production and use |
02/01/2012 | CN101113166B 肺炎嗜衣原体的一种重组主要外膜蛋白及其制备方法 An addicted Chlamydia pneumoniae recombinant major outer membrane protein and its preparation method |
02/01/2012 | CN101035897B 用于预防和治疗hiv感染的疫苗 For the prevention and treatment of hiv infected vaccine |
01/31/2012 | US8106274 Tomato line PSQ24-2206 |
01/31/2012 | US8106273 Tomato line CHI 128-6025 |
01/31/2012 | US8106252 Use of recombinant polypeptides from a lupinus plant and nucleotide sequences encoding it as plant growth promoters, antimicrobial or insecticidal |
01/31/2012 | US8106171 Nel-related type 1 polypeptide |
01/31/2012 | US8106164 Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof |
01/31/2012 | US8106162 Artificial antibody polypeptides |
01/31/2012 | US8106160 N-terminal modified interferon-alpha |
01/31/2012 | US8106159 Insecticidal toxin complex fusion protiens |
01/31/2012 | US8106158 Compositions and methods for fusion protein separation |
01/31/2012 | US8106156 PRO1120 polypeptides |
01/31/2012 | US8106154 Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules |
01/31/2012 | US8106152 Antimicrobial composition |
01/31/2012 | US8106098 Protein conjugates with a water-soluble biocompatible, biodegradable polymer |
01/31/2012 | US8106027 Development of a preventive vaccine for filovirus infection in primates |
01/31/2012 | US8106026 Development of a preventive vaccine for filovirus infection in primates |
01/31/2012 | US8106015 Method for enhancing immune response with peptide |
01/31/2012 | US8106013 ABC transporter ligand GATX1 |
01/31/2012 | US8106010 Variants of pigment epithelium derived factor and uses thereof |
01/31/2012 | US8106009 by administering a midkine family protein, optionally in combination with other neurotrophic factors. |
01/31/2012 | US8106007 Having affinity to antithrombin III; improved pharmacokinetic properties when compared to the original polypeptides |
01/31/2012 | US8106006 Modified defensins and their use |
01/31/2012 | US8106005 Modulating apoptosis |
01/31/2012 | US8106002 Anti-cancer agent comprising protein C inhibitor |
01/31/2012 | US8105842 Interleukin-13 as a cardiovascular disease marker |
01/31/2012 | US8105839 Diagnostic kit for Alzheimer's disease, diagnostic marker, and detection method for indicator of pathological state thereof |
01/31/2012 | US8105830 Polyspecific binding molecules and uses thereof |
01/31/2012 | US8105825 Multiple inducible gene regulation system |
01/31/2012 | US8105816 Nucleic acid molecules encoding BANK1 splice variants |
01/31/2012 | US8105815 Asparaginase and its use in food production |
01/31/2012 | US8105803 Phosphatases involved in the regulation of cardiomyocyte differentiation |
01/31/2012 | US8105799 Using transforming growth factor-beta -activated kinase-1 (TAK-1) and TAK1 binding protein 1(TAB-1) as evaluative tool in detection of modulators of interleukin and tumor necrosis factor activities |
01/31/2012 | US8105791 Marker for stem cells and its use |
01/31/2012 | US8105789 Diagnosis and treatment of infectious diseases through indel-differentiated proteins |
01/31/2012 | US8105785 Mylks as modifiers of branching morphogenesis and methods of use |
01/31/2012 | US8105774 Using peroxisome proliferator-activated receptor gamma, coactivator 1 beta (PGC-1Beta) as tool to identify modulators for treatment of free radical associated disorders |
01/31/2012 | US8105629 Collagen gel and process of producing the same |
01/31/2012 | US8105610 Method of making novel erythrovirus V9 VP2 capsid polypeptides |
01/31/2012 | US8105609 Administering a vaccine of a nucleic acid having a transcriiptional unit (TU) to direct a host cell to to biosynthesize the matrix and envelope (M and E) protein antigens; the TU comprises a prM signal sequence and ribosomal bindng sequence; carriers; encephalitis and yellow fever |
01/31/2012 | US8105607 Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia |
01/31/2012 | US8105606 Chimeric proteins that induce effects directed against viruses |
01/31/2012 | US8105604 WT1 modified peptide |
01/31/2012 | US8105603 Polypeptides that bind APRIL |
01/31/2012 | US8105596 Immunotherapy of B-cell malignancies using anti-CD22 antibodies |
01/31/2012 | US8105590 Methods of treating inflammation in neuronal tissue |
01/31/2012 | US8105589 Use of DR3 antibodies in the treatment of inflammatory disease |
01/31/2012 | US8105574 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
01/31/2012 | US8105573 Protease resistant modified IFN beta polypeptides and their use in treating diseases |
01/31/2012 | US8105572 Method of treating tuberculosis with interferons |
01/31/2012 | US8105571 Method of treating pulmonary disease with interferons |
01/31/2012 | US8105084 Interactive dental restorative network |
01/31/2012 | US8104533 Spray nozzle apparatus and method of use |
01/31/2012 | CA2520537C Process for producing plant storage organ with high production of recombinant protein and novel recombinant protein |
01/31/2012 | CA2496897C Methods and compositions for modulating xbp-1 activity |
01/31/2012 | CA2493539C A method for purifying preproinsulin |
01/31/2012 | CA2443947C Recombinant p. vivax merozoite protein-1 p42 vaccine |
01/31/2012 | CA2432370C Attenuated flaviviral live vaccine comprising a capsid protein deletion |
01/31/2012 | CA2393251C Eliciting hcv-specific antibodies |
01/31/2012 | CA2339889C Identification of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests |
01/31/2012 | CA2285672C Purified telomerase |
01/31/2012 | CA2274989C Cloned glucagon-like peptide-2 receptors |
01/31/2012 | CA2274303C Synthetic bi-epitope compounds useful as standard measure in biological dosage of troponin i |
01/31/2012 | CA2233670C Mutant plasminogen activator-inhibitor type 1 (pai-1) and uses thereof |
01/31/2012 | CA2226087C Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
01/26/2012 | WO2012012802A2 Neoepitope detection of disease using protein arrays |
01/26/2012 | WO2012012773A1 Manufacture of inter -alpha - inhibitor proteins (iaip) from plasma |
01/26/2012 | WO2012012656A2 Materials and methods for treating neurodegenerative diseases |
01/26/2012 | WO2012012531A2 Compositions and methods featuring il-6 and il-21 antagonists |
01/26/2012 | WO2012012271A2 Novel glycosylated polypeptides |
01/26/2012 | WO2012012141A1 Scnn1a/tnfrsf1a fusion proteins in cancer |
01/26/2012 | WO2012011992A2 Ricin vaccine and methods of making and using thereof |
01/26/2012 | WO2012011848A1 Polypeptide having antibacterial activity and suitable for producing drugs for the treatment of bacterial infections in humans |
01/26/2012 | WO2012011836A1 The new stable polyethylene glycol conjugate of interferon alpha, represented by one positional isomer |
01/26/2012 | WO2012011752A2 Novel long-acting glucagon conjugate and pharmaceutical composition comprising the same for the prevention and treatment of obesity |
01/26/2012 | WO2012011381A1 Malaria vaccine |
01/26/2012 | WO2012011144A2 Use of amino acid sequences from mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom. |
01/26/2012 | WO2012011114A2 Sequence specific double-stranded dna/rna binding compounds and uses thereof |
01/26/2012 | WO2012010872A2 Plant cytochrome p450 |
01/26/2012 | WO2012010855A1 Intracellular immunity |
01/26/2012 | WO2012010849A2 Methods of diagnosis and vaccines |
01/26/2012 | WO2012010686A1 Invention relating to flocculation |
01/26/2012 | WO2012010674A1 Nkx2.2 inhibitors as drugs |
01/26/2012 | WO2012010321A1 Foetal haemoglobin inhibitor |